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This study investigated the eﬀect of attending pre-school on mucosal immunity. Children 3.5 to 5 years of age who attended
pre-school were observed for a 10 month period. Demographic information was collected on previous childcare experiences, the
home environment and clinical information relating to the child and the family. A daily illness log was kept for each child. A
multivariate longitudinal analysis of the relation between immunoglobulins in saliva and age, gender, childcare experience, pre-
school exposure, number of siblings, environmental tobacco smoke (ETS), atopy and hospitalisation was conducted. There was
a positive association of higher IgA levels with the winter season and with children being older than 4 years (P<. 001), having
attendedchildcarepriortocommencingpre-school(P<. 05),andhavingbeenexposedtoETSathome(P<. 05).LowerIgAlevels
were associated with being atopic (P<. 05). Higher IgG levels were associated with exposure to ETS (P<. 001), while lower levels
were associated to having atopy. Higher IgM levels were associated with previous childcare experience (P<. 01) whilst having
been hospitalised was associated with having low salivary IgM levels (P<. 01). Lagged analyses demonstrated that immunological
parameters were aﬀected by the number of respiratory infections in the preceding 2 months.
1.Introduction
The mucosal immune system begins to develop shortly
after conception, and whilst structurally complete at birth,
it is functionally immature [1]. Functional development
is rapidly stimulated after birth by the ingestion and
inhalation of bacterial and food antigens and mitogens. The
salivary glands have long been recognised as part of the
common mucosal immune system [2], and as such, salivary
secretions have been often used to assess mucosal immune
competence in humans. Numerous studies have looked at
the development of the mucosal immune system in the
early years of childhood in order to gain some insight into
the maturation of the host mucosal defences in children.
Whilstsomehaveshownthatsalivaryimmunoglobulinlevels
continue to increase throughout the childhood years [3],
others have found that adult levels are reached by seven years
[4–8]a n de v e na se a r l ya s1 2t o1 8m o n t h so fa g e[ 9, 10].
Although the literature is not conclusive on the postnatal
ontogeny, what is clear is that the timing and pattern of
the increase from infant to adult levels appear to depend on
environmental inﬂuences [11–14].
The development of mucosal immunity is profoundly
aﬀected by exposure to infection. The ontogeny patterns for
mucosal antibodies in young children appear to reﬂect the
degree of antigenic exposure in their environment. Increased
antigenic exposure of infants through poor hygiene and
health in developing countries [13, 14] and hospitalisation
or daycare attendance in developed countries [9] results
in high levels of antibodies in saliva that can occur at an
earlier age [13, 14]. Early life events appear to have a critical
inﬂuence on the ultimate pattern of immune maturation2 Clinical and Developmental Immunology
[1], and there has been a pressing need for longitudinal
studies to understand how immune responses evolve in
children and the impact on long-term clinical outcomes.
However, to date, much of the information regarding the
impact of environmental stimuli on the developing immune
system has been anecdotal. The common interpretation is
that older siblings and childcare attendance are indirect
measures of early life infections and that early life infections
have a preventative eﬀect on the development of atopic
disorders [15] and infectious illness. This study was designed
to examine several factors that may impact the development
of mucosal immunocompetence in young children. Children
were studied during their pre-school year as this would be
their ﬁrst encounter with the increased antigenic exposure
associated with starting school. Children aged 3.5 to 5
years attending pre-school were monitored for one school
year (February to December) to ascertain whether any
alteration in mucosal immune function could be linked
to environmental, developmental, and clinical events. The
eﬀects were monitored using various markers of potential
mucosal immune stimuli, such as the number of siblings in
thefamily,daysofattendanceatdaycarefacilities,andknown
modiﬁers of mucosal immunity such as environmental
tobacco smoke (ETS) exposure. A record was kept of the
general health status of the children during the year and
episodes of gastrointestinal tract (GIT), and respiratory (RT)
symptoms were recorded by the parents. Saliva samples were
collected at regular intervals throughout the year and were
analysed for immunoglobulin levels IgA, IgG, and IgM and
Escherichia coli-speciﬁc IgA antibodies.
2. Methods
2.1. Study Population. After obtaining written informed
consent, 37 children, aged 3.5–5 years, were recruited from
a single pre-school on the south coast of NSW, Australia.
All of the children had been fully immunised in accordance
with the Australian National Health and Medical Research
Council recommended vaccination schedule [16]. The pre-
school had a total annual enrolment of 100 to 120 children,
aged between 3 and 6 years of age. Class sizes were
approximately 25 children each day. Ethical approval for the
study was provided by the Committee for Ethics in Human
Research at the University of Canberra.
2.2. Data Collection. Information on the child’s health and
environmental exposures was collected from parents by
questionnaires prior to commencement of the study. The
baseline questionnaires collected three sets of information:
individual, family, and clinically related information. Indi-
vidual characteristics included child’s age, gender, number of
days the child would be attending pre-school, previous pre-
school or childcare centre arrangements. Previous childcare
arrangement was deﬁned as a formal childcare centre.
Family characteristics included number and age of siblings,
and number of people who smoked tobacco in the home.
Clinically related information included: atopy deﬁned as
eczema, asthma, urticaria, or known allergy to food or
inhaled allergens; medications taken by the child; previous
major illness, hospitalization, or dental treatment.
Thechild’sagewasmeasuredinmonthsandwasgrouped
as a 2-category classiﬁcation: children that were 4 years and
younger and children that were older than 4 years.
2.3. Infection Data. Saliva samples were collected in Febru-
ary, April, July, September, and December, and collections
were spread over three days of the week on each occasion.
The pattern of attendance at the pre-school ensured that the
same children were always present on Day 1, Day 2, and
Day 3, respectively, so the number of days between saliva
collection events was the same for all children. Infection
records were related to saliva samples by dividing the year
into four periods, these being the periods between one saliva
collection event and the next. Infection records started from
the beginning of February when the ﬁrst saliva samples were
collected. This was the beginning of the school year, in the
latter part of the Australian summer season.
2.4. Infectious Exposures
2.4.1. Respiratory and Gastrointestinal Symptoms. Over the
10-month study period from February to December, parents
were asked to record any symptoms of RT or GIT infections
on a calendar for each month. An infectious episode was
deﬁned as the acute occurrence of a new symptom lasting
for at least 1 day with fever. A visit to the doctor and
temperature was recorded if the child was ill. GIT illness-
related symptoms included: fever, vomiting, diarrhoea and
tummy ache. RT symptoms included: fever, vomiting, runny
nose, cough, wheezing or whistling breathing, diﬃculty
breathing, and ear ache.
2.4.2. Indirect Measures of Exposure to Infectious Agents.
Indirect measures of exposure to infectious agents included:
previous attendance at a childcare centre (measured as
the number of days per week at a childcare centre and
categorized as “low”—<2d a y sp e rw e e kf o r<1y e a ro r
“high”—≥2d a y sp e rw e e kf o r≥1y e a r ) ;n u m b e ro fd a y s
in attendance at pre-school (measured as 1 or 2 days per
week); any history of hospitalisation or intrusive medical
procedures; older siblings (measured as birth order when
the child was included in the study cohort), and number of
siblings in the family. The categorization of these measures
of exposure is presented in Table 1.
2.5. Covariates. The determinants of interest included gen-
der, atopy, and ETS exposure. Atopy was deﬁned as a history
of eczema, asthma, urticaria, and allergy. Exposure to ETS
was deﬁned as living in the same household as ≥1s m o k e r .
The categorization of these covariates is presented in Table 1.
2.6. Laboratory Analyses
2.6.1. Sample Collection. Saliva samples were collected as
previouslydescribedin[17]on5occasionsduringtheschool
year in the months of February, April, July, September, andClinical and Developmental Immunology 3
Table 1: Demographic characteristics of the study population (n = 37).
Variables Deﬁnition and description Distribution
Demographic variables
Age
≤4 years of age 15 (45.5%)
>4 years of age 22 (54.5%)
Gender Female 21 (56.8%)
Male 16 (43.2%)
Having attended childcare previously No 8 (21.6%)
Yes 29 (78.4%)
No. of days at pre-school Low—<2d a y s / w e e kf o r<1 year 13 (35.1%)
High—≥2d a y s / w e e kf o r≥1 year 24 (64.9%)
Household environment variables
Having siblings No 16 (43.3%)
No. of siblings Yes 21 (56.7%)
2.51a (0.77)
ETS exposure in home No 23 (63.2%)
Yes 14 (37.8%)
Medical history
Having atopy No 31 (83.8%)
Yes 6 (16.2%)
Having been hospitalised No 23 (62.2%)
Yes 14 (37.8%)
aThe arithmetic mean of the number of siblings (and standard deviation) is reported for this covariate.
December. All samples were collected between 0900 and
1100 hours according to standardised procedures [18, 19].
Approximately 1mL of saliva was collected from each child
on each occasion and stored at −70◦C for later analysis of
the immunoglobulins IgA, IgG, IgM and E. coli-speciﬁc IgA
antibody levels and total protein concentration.
2.6.2. Measurement of IgA, IgG, and IgM in Saliva. IgA, IgG
and IgM were measured in saliva by an in-house indirect
enzyme-linked immunosorbent assay (ELISA) as previously
described in [17].
2.6.3. Measurement of IgA Speciﬁc Antibodies to E. coli
O Antigen in Saliva. An in-house ELISA measured IgA
antibodies against E. coli O antigens as described previously
[7].
2.6.4. Measurement of Total Salivary Protein. The commer-
cially available BCA protein assay kit (Pierce Biotechnology
Inc, Rockford, Illinois, USA) was used to measure the total
protein concentration of the saliva samples.
2.7. Statistical Analysis. Hypotheses were tested with a series
of mixed eﬀects multilevel regressions performed using the
xtmixed procedure of Stata [20]. Multilevel modelling is a
contemporary approach to longitudinal designs [21]s u c h
as that used in the present study that provides ﬂexibility in
analysing hierarchical data sets. The use of the multilevel
approach maximises available data in that protocols from
any child whose provided readings are included in the
estimation.
A separate analysis was conducted for each of the log-
transformed immunoglobulin outcomes as well as for total
number of illness events (untransformed). In each analysis,
a time variable representing the ﬁve sample points coded
as 1 to 5 was entered into the model to represent linear
change in the outcome over the year. As well, the square
of the time variable was entered to account for curvilinear
change. The covariates were entered, and where necessary,
were coded as representative variables for age (≤4y e a r so f
age versus >4 years of age); gender (male versus female);
having attended previous childcare (no versus yes); amount
of pre-school exposure (“low”—<2d a y sp e rw e e kf o r<1
year versus “high”—≥2d a y sp e rw e e kf o r≥1 year); siblings
(no versus yes); parental smoking (no versus yes); atopic (no
versus yes); previous hospitalisation (no versus yes). These
predictors accounted for diﬀerences in levels of the salivary
immunoglobulinoutcomesovertheyear.Thecorresponding
multilevel regression coeﬃcients were calculated and are
shown in Table 3. In order to examine further eﬀects of the
predictors on the rate of change in immunological outcomes
over the course of the year, a set of products were calculated
from the time variable, and each of the respective predictors
and these products were entered as predictors in their own
right. Predictors were not entered prior to the formation
of the products as most were representative variables (see
above) or otherwise contained meaningful zero points. Any
signiﬁcant changes observed in the analyses are reported in
results. The eﬀects of mucosal illness on immunoglobulin
levels were examined using a series of lagged analyses in4 Clinical and Developmental Immunology
Table 2:Salivaryimmunologicalparameters,reportedasgeometricmeanand95%conﬁdenceinterval(CI),ateachassessmentpointduring
the pre-school year.
Saliva collection time
12345
February
(summer end)
geometric mean
(95% CI)
April
(autumn)
geometric mean
(95% CI)
July
(winter)
geometric mean
(95% CI)
September
(spring)
geometric mean
(95% CI)
December
(presummer)
geometric mean
(95% CI)
IgA
(mg/L)
21.83
(18.99–25.10)
21.07
(18.20–24.40)
30.27
(25.72–35.61)
20.65
(17.48–24.39)
22.12
(18.85–25.97)
IgG
(mg/L) 2.99 (2.34–3.82) 2.89 (2.29–3.66) 2.32 (1.86–2.91) 3.03 (2.26–4.06) 2.87 (2.16–3.82)
IgM
(mg/L) 0.87 (0.64–1.17) 0.96 (0.73–1.26) 0.81 (0.63–1.04) 1.04 (0.83–1.31) 1.10 (0.81–1.48)
E. coli-
speciﬁc
IgA
antibody
(EU/mL)
0.11 (0.09–0.14) 0.08 (0.06–0.09) 0.10 (0.09–0.12) 0.12 (0.09–0.16) 0.11 (0.09–0.13)
whichthenumberofpriorRTandGITinfectionsreportedat
each sampling point was entered in multilevel mixed-eﬀects
regressions with a lag of approximately 2 months to each
immunoglobulin outcome.
To allow for the dilution eﬀect of diﬀering ﬂow rates,
total salivary immunoglobulin levels were analysed both
c o r r e c t e da n du n c o r r e c t e dw i t hr e g a r dt ot o t a lp r o t e i n
levels. No diﬀerence was found in the results obtained for
the corrected and uncorrected data (data not shown). The
salivary immunoglobulin data presented for this study is
uncorrected for total protein levels (Table 2).
3. Results
3.1. Demographics of the Study Cohort. The general charac-
teristics for the children in the study are provided in Table 1.
Of the total 37 children, 46% of children were 48 months
of age or younger, and 55% were older than 48 months
but no older than 60 months. There were approximately
equal numbers for each gender, 57% females and 43% males.
The majority of children (78%) had previously attended
formal childcare prior to starting pre-school. About two
thirds of the children studied attended pre-school for 2 days
per week, and about one third were attending 1 day per
week. More than half of the children had siblings, and over
a third were reported to live in a household with a smoker.
Approximately 16% of children had an allergic disease, and
38% had previously been hospitalised.
3.2. Seasonal and Age-Related Changes in Salivary Immune
Parameters. A total of 164 saliva samples, were collected for
statistical [22] analysis. Twenty-two children (59.5%) had a
completesetof5salivasamplesandafurther6(16.2%)had4
salivasamplescollected.Table 2 showsthegeometricmeanof
salivary IgA, IgG, and IgM and E. coli-speciﬁc IgA at each of
the 5 assessment points during the school year in the months
of February, April, July, September, and December with
the July assessment point representing the southern hemi-
sphere winter. The salivary immunoglobulin concentrations
were compared to age-related reference ranges. The salivary
IgA levels were predominantly within the reference range,
with levels above the population age reference range being
recorded for 20 (11.5%) samples. The highest level recorded
was80.4mg/L.Tenofthesampleswithelevatedlevelsoftotal
IgA were collected in July. There was a strong seasonal rise in
salivary IgA associated with the southern hemisphere winter
(Table 2). Signiﬁcant linear (regression coeﬃcient 0.172
(standard error 0.071; P<. 05) and curvilinear (regression
coeﬃcient −0.043 (standard error 0.071; P<. 05) changes
were found for the total salivary IgA levels only (Table 3).
The concentration of salivary IgA remained relatively stable
during the time period from February to April (geometric
mean21.83mg/L; 95% conﬁdenceinterval (CI),18.99–25.10
and 21.07mg/L; 95% CI, 18.20–24.40, resp.), then increased
to a mean high of 30.27mg/L (95% CI, 25.72–35.61) during
July,andthenshowedadownwardtrendto22.12mg/L(95%
CI 18.85–25.97) in December, similar to those values seen at
the beginning of the pre-school year.
The levels of salivary IgG and IgM measured in this
study were all within their respective age-related reference
ranges.TherewasnoassociationbetweensalivaryIgGorIgM
levels and the time of year that the samples were collected.
The IgG level in saliva showed a nonsigniﬁcant downward
trend from 2.99mg/L (95% CI, 2.34–3.82) at the start of
the school year to a low of 2.32mg/L (95% CI, 1.86–2.91)
during July followed by a high of 3.03mg/L (95% CI, 2.26–
4.06)inSeptember,afterwhichtimeitreturnedinDecember
to levels observed in February. Salivary IgM levels tended to
ﬂuctuate during the course of the year from 0.87mg/L (95%
CI, 0.64–1.17) in February to 1.10mg/L (95% CI, 0.81–1.48)
in December, but showed no signiﬁcant trend over the year.
Levels of E. coli-speciﬁc IgA antibodies were measured
using antigen pooled from four enteric strains of the bac-
terium.Noreferencerangehasbeenestablishedforthisassay.Clinical and Developmental Immunology 5
Table 3: Regression coeﬃcients (standard errors in parentheses) for multilevel regressions on each immunological outcome.
Immunological outcome
Predictor IgA IgG IgM E. coli
Time eﬀect linear 0.172∗ (0.071) −0.103 (0.109) −0.021 (0.121) −0.058 (0.099)
Time eﬀect curvilinear −0.043∗ (0.017) 0.021 (0.026) 0.018 (0.029) 0.020 (0.024)
Aged older than 4 years 0.271∗∗∗ (0.081) 0.152 (0.132) 0.3218 (0.139) 0.091 (0.119)
Female −0.035 (0.089) 0.159 (0.147) 0.120 (0.155) −0.279∗ (0.132)
Previous childcare experience 0.185∗ (0.092) −0.040 (0.150) 0.473∗∗ (0.157) 0.329∗ (0.136)
High pre-school exposure −0.166 (0.090) −0.317∗ (0.146) −0.211 (0.154) 0.401∗∗ (0.132)
Having siblings 0.028 (0.056) −0.107 (0.092) 0.130 (0.097) 0.070 (0.084)
ETS exposure 0.205∗ (0.082) 0.453∗∗∗ (0.134) 0.087 (0.141) −0.075 (0.121)
Having atopy −0.216∗ (0.103) −0.372∗ (0.168) −0.025 (0.177) 0.199 (0.151)
Having been hospitalised −0.002 (0.096) 0.151 (0.157) −0.412∗ (0.165) −0.125 (0.141)
Note.O u t c o m e sa r el o g t r a n s f o r m e d .
Signiﬁcance of associations: ∗P <. 05; ∗∗P <. 01; ∗∗∗P <. 001.
Saliva levels of E. coli-speciﬁc IgA antibodies measured in
pre-school children tended to remain relatively stable during
the course of the pre-school year from a low geometric mean
of 0.08EU/mL to a high of 0.12EU/mL.
3.3. Multivariate Longitudinal Analysis. The results of the
multivariatelongitudinalanalysisoftherelationshipbetween
salivaryIgA,IgG,andIgMandE.coli-speciﬁcIgAantibodies,
and age, gender, prior childcare experience, length of pre-
school attendance, number of siblings in the family, ETS
exposure, atopy, and hospitalisation are provided in Table 3.
Longitudinal analysis conﬁrmed the strong positive associ-
ation of higher IgA levels, but not the trajectory of these
over time, with children being aged older than 4 years at
the onset of the study (P<. 001), having attended childcare
prior to commencing pre-school (P<. 05), and having been
exposed to ETS at home (P<. 05). Lower salivary IgA
levels were strongly associated with being atopic (P<. 05).
There was no signiﬁcant association between the salivary IgA
levels and gender, length of pre-school attendance, number
of siblings in the family, or having been hospitalised. There
was a signiﬁcant association between higher salivary IgG
levels and having been exposed to ETS (P<. 001). Lower
salivary IgG levels were associated with higher number of
days in attendance at pre-school (P<. 05) and having atopy
(P<. 05). Higher salivary IgM levels were associated with
previous childcare experience (P<. 01). A history of having
been hospitalised was associated with having low salivary
IgM levels (P<. 05). Higher E. coli-speciﬁc IgA levels were
associated with previous childcare experience (P<. 05) and
higher attendance days at pre-school (P<. 01). Female
gender was correlated to having lower E. coli antibody levels.
None of the rates of change of immunological variables
were associated with any of the covariates examined in the
study.
3.4. Eﬀect of Infection. Records of illness in the children were
studied for possible correlation with salivary antibody levels.
Compliance varied greatly with 23 (56.1%) of the children
having a complete record for the whole 10 months of the
study. Of the children who were included in the statistical
analysis, 62.2% had complete infection data records for the
study period. In the study population, 34 of the children
(91.9%) experienced at least 1 RT symptom during the
school year. As expected, during the winter ﬂu season,
children were more likely to experience an RT illness with
a total of 39.3% of episodes occurring during the months
of May, June, and July. Twenty-eight (75.7%) children
experienced a RT infection during the winter months. The
incidenceofRTinfectionsreportedwashighestinthemonth
of June (23.4%). Thirty-one (83.8%) children experienced
at least one GIT symptom during the school year. The
majority of episodes occurred in the early part of the year
when the children were newly enrolled in pre-school. The
number of episodes fell from a high of 20.0% of children
with reported cases in February to a low of 4.4% in October.
Approximatelyonethirdofthechildren(35.1%)experienced
a GIT infectious episode with 35.0% of infections occurring
in the ﬁrst month of pre-school. Lagged analyses showed
that immunoglobulin levels were primarily aﬀected by the
number of RT infections in the preceding two months,
and not, by GIT infections. There was a strong inverse
relationship between the number of RT infections and the
levels of salivary IgA and IgG. The corresponding regression
parameters (and standard errors) for RT infections for
salivary IgA and IgG, respectively, were −0.044 (standard
error 0.021; P = .039) and −0.085 (standard error 0.031;
P = .007).
4. Discussion
This study of 37 children aged 3.5–5 years attending a
single Australian pre-school for one school year establishes
longitudinal data on (1) the development of total salivary
immunoglobulins IgA, IgG, and IgM, and IgA antibody
speciﬁc against E. coli O antigen; (2) the inﬂuence of age
on these parameters; (3) the impact of season and infection
on immune parameters; (4) environmental factors which
aﬀectthepatternofimmunoglobulinontogenyandantibody
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Using a standardised protocol [18], saliva samples were
collected from pre-school children at 5 diﬀerent time
intervals during the school year. Immunoglobulin levels
were found not to diﬀer signiﬁcantly at the end of the
study compared to those at the beginning of the year.
The geometric mean levels for IgA, IgG, and IgM during
the course of the study varied between 20–30mg/L, 2.3–
3.0mg/L, and 0.8–1.1mg/L, respectively, similar to those
previously reported for children in the same age range [22].
Children older than 4 years of age had higher levels of
salivary IgA when compared with younger children. This
observation is consistent with previous studies of mucosal
immune ontogeny [7, 9, 14, 23] .T h el a c ko fi n c r e a s ei n
immunoglobulin levels during the course of the pre-school
year is in contrast with the ﬁndings of a larger cross-sectional
study of Australian children conducted in the early 1980s
[7] which showed a dramatic increase in salivary IgA levels
in children who completed their ﬁrst year of school. It is
speculated that the cohort of children studied previously
may have been immunologically na¨ ıve and showed a marked
increase in mucosal immunoglobulin levels as a result of a
large increase in antigenic exposure associated with starting
school.However,socialandeducationpatternshavechanged
since this earlier study, and many children now spend some
time in childcare centres from an early age with the majority
of Australian children spending at least a year in pre-school
before they start their formal school education. It would
seem that children today are exposed to a wide range of
environmental antigenic challenges at an earlier age.
To assess the pattern of development of speciﬁc immu-
nity in the mucosal system to a common gut antigen,
IgA antibodies speciﬁc to E. coli somatic O antigen were
measured in saliva. Consistent with earlier studies [7, 9],
low levels of E. coli-speciﬁc IgA O antigen antibodies were
detectedinthesalivaofthechildreninthisstudy.Theselevels
remained relatively constant during the course of the pre-
schoolyearsuggestinguniversalexposuretothisbacteriaand
a closely controlled mucosal response to a major colonizing
antigen.
Similar to other studies of pre-school-aged children [24–
27], respiratory and enteric illnesses were common in this
study group. Increased exposure to other children, and to
the common pathogens they carry, has been identiﬁed as
the primary risk factor for elevated rates of illness among
children in group care [24, 26–29], in particular, GIT illness
[27–29],RT,andearinfections[24,27,29,30].Thereissome
anecdotal evidence to suggest that immunity acquired in
these settings might protect the child on entrance to primary
school [26]. In this study, longitudinal observation of chil-
dren’ssymptomsshowedmoreboutsofRTillnessinthewin-
ter months which was signiﬁcantly associated with elevated
salivary IgA levels. Levels of salivary immunoglobulins are
known to change rapidly during the course of an infection,
particularly with respect to respiratory infections [18, 31–
33]. Total salivary IgA levels have been shown to increase
within 1–4 days of the onset of upper respiratory tract
symptoms and to fall to preinfection levels within 12 days
of appearance of symptoms [18]. This response to infection
tends to be large and polyclonal whenthe antigenic challenge
is new. Lagged analysis of the longitudinal data showed that
salivary IgA and IgG levels were primarily aﬀected by the
number of respiratory infections in the preceding 2 months.
Those children with low levels of salivary IgA and IgG had
the greater number of RT infections. Similar observations
have been made in high performing athletes [34] and in
children prone to respiratory infections [35]. More than a
thirdofGITinfectionswerereportedintheﬁrstmonthofthe
pre-school year. This may reﬂect exposure to microbial ﬂora
not previously encountered and corresponds to previous
ﬁndings that the pathogens associated with GIT illness are
so ubiquitous and virulent in this environment [36, 37]
that the risk of contracting a communicable infection for
children is greatest immediately after entering a new group
care arrangement [27, 38]. The fall in the incidence of
such infections later in the year may indicate that the
children have acquired some immunity to these pathogens
or that the microbes in question are more prevalent in
the summer months. There was, however, no signiﬁcant
increase in mucosal immunoglobulin levels observed in
association with the increase in episodes of GIT symptoms.
The immune system of the young child is in a constant
stage of development and maturation and therefore is most
vulnerable to environmental exposure. Microbial exposure
early in life may potentially inﬂuence the development of
immune networks in the airways [39], or the type of GIT
ﬂora encountered may modulate mucosal immune responses
[40]. Such events at mucosal surfaces can impact not only
on local responses, but also on responses at distant sites
[2]. Central to the “hygiene hypothesis” [41] is the concept
that overt infections and exposure to nonviable microbial
compounds in the environment might confer protection
from the development of allergic illness. In population based
studies, various markers of infection burden, such as daycare
attendance in infancy [42–46], infection, and the number of
older siblings [44, 46–49], have been shown to be inversely
associated with atopy-related disorders. The total burden of
recurrent RT infections during the early years of life have
also been shown to be negatively associated with atopy at
pre-school [45] and at school age, in cross-sectional surveys
[47, 49]. Among children at risk for atopic-related illness,
exposure to rhinitis, croup, and recurrent ear infection early
in life shows protection from atopy at school age [50–52].
Whilst a large number of epidemiological and longitudinal
studies have looked at the “hygiene hypothesis” and the
development of allergic illnesses, the question as to whether
exposure to early infections has a causal or protective eﬀect
for future allergic disease remains controversial [22, 53].
However, as a result of these ongoing investigations, this
hypothesis has evolved in various ways to show that the
relationship between early-life illnesses and allergic disease
is complex with emerging concepts related to the underlying
innate and adaptive immune response mechanisms involved.
In this study group, it was found that atopic disease was
strongly associated with low levels of salivary IgA and IgG.
In previous studies from our group, we have demonstrated
that bronchial hyperreactivity was associated with the extent
of salivary IgA deﬁciency in the ﬁrst year of life [15]a n d
that children born to atopic parents have signiﬁcantly lowerClinical and Developmental Immunology 7
levels of salivary IgA compared with children of non-atopic
parents [54]. The incidence of allergic disease in this study
was similar to that which we observed in our earlier studies
[54] .T h e r ei sn o we v i d e n c et os u g g e s tt h a tm u c o s a lI g A
may have a protective role against the development of
allergic sensitization in young children [55, 56], although,
consensus is yet to be reached [33]. Children who had
previous exposure to daycare were signiﬁcantly more likely
to have higher salivary IgA and IgM levels. The increase in
salivaryIgAreﬂectsgutstimulationandtherepertoireofgut-
associated antigens [57], while salivary IgM [9, 18, 32, 58]
has been occasionally observed in infants and adults in
a pattern consistent with the concept that the occurrence
of IgM in mucosal secretions reﬂects immune responses
to novel antigens presented at mucosal sites, particularly
the GIT [59]. Interestingly, reduced levels of salivary IgG
were associated with increased pre-school exposure. One
possible explanation is that the mucosal immune response is
downregulated in response to high levels of antigen exposure
[60]. Of the children in the current study that had a medical
history of being hospitalised, over half of the hospitalisations
were a result of infections or complications related to
infections during the ﬁrst two years of life (data not shown).
The low salivary IgM observed in this subgroup may identify
a risk factor for susceptibility to infection in these children,
and further studies are required to determine possible
mechanisms causing these lower levels of mucosal IgM in
young children prone to infection. In another study [9]
where children were hospitalised predominantly for surgical
procedures, the IgM antibody levels were similar to those
observedinnonhospitalisedchildren.HigherlevelsofE.coli-
speciﬁcIgAantibodieswerestronglyassociatedwithchildren
who had previous daycare experience and attended pre-
school for two or more days a week compared to those that
attended less frequently. This corresponds with the previous
ﬁnding that, for pre-school-aged children, the number of
hours spent in group care settings increases the likelihood
of a child contracting a GIT illness [28], most probably due
to increased contagion exposure. Interestingly, there was a
sex-related diﬀerence in the immune response with respect
to girls having lower levels of IgA speciﬁc antibody to E. coli.
This suggests that the girls may have been exposed to lower
levels of GIT pathogens and corresponds to the ﬁndings
that boys have a higher incidence of contracting a GIT
illness [38, 61]. Surprisingly, there was no association found
between the number of siblings in the family and salivary
immunoglobulin or E. coli-speciﬁc IgA antibody levels and
suggests that close social interaction outside the home is a
greater determinant of mucosal immune stimulation.
Perhaps the most ubiquitous and hazardous of children’s
environmental risks is exposure to ETS. Extensive literature
links passive smoking with a wide range of eﬀects on
mortality and morbidity in children [62–65]. Exposure
to cigarette smoke has been associated with abnormal
mucosal development in children [66]; mucosal immune
dysregulation in infants [67]; airway irritation that can result
in local epithelial damage [68, 69]; airway inﬂammation
which can adversely aﬀect mucocilliary clearance [69, 70];
increased risk of carriage of potentially pathogenic bacteria
[71] and dental caries [72] in children. Higher mucosal
IgA levels in the infants of smokers have been attributed to
more chronic upper RT symptoms [32, 33] which may be
associatedwithincreasedadherenceofrespiratorypathogens
to buccal epithelial cells [73]. In our study cohort, exposure
to ETS was associated with elevated salivary IgA and IgG
concentrations. In contrast to our observations, another
study [74] found that the salivary IgA concentration was
decreased in 4–6-year-olds exposed to ETS. The apparent
disparity in results may be due to the use of diﬀerent saliva
collection and assay methods, or more importantly, the
cohort of children studied. In the study by Avs ¸ar et al. [74],
children who attended kindergarten were excluded from the
study, as a consequence, these children in their study may
not have experienced the same degree of antigenic challenge
as the children in our study.
In conclusion, this study clearly demonstrates that expo-
sure of children to environmental stimuli and noxious agents
such as tobacco smoke has a profound eﬀect on mucosal
immune status and the potential for clinical sequelae. A
large birth cohort study is currently being conducted in
which the ontogeny proﬁles of salivary IgA and speciﬁc
salivary IgA antibodies to common respiratory pathogens
from birth to 5 years of age are being determined. This
study will examine the eﬀect of upper airway microbial
colonization, ETS exposure, and other environmental factors
on mucosal immune status and susceptibility to otitis media.
A clear understanding of the way in which these factors
interact with the mucosal system to inﬂuence development
and control of immune function will assist in developing
disease management strategies.
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